Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
10/2006
10/25/2006CN1281753C Monoclonal antibody CAb-1 heavy and light chain variable region gene of human carcinoma of large intestine, and its uses
10/25/2006CN1281751C DNA mark for inspecting purity of seeds and method thereof
10/25/2006CN1281739C Isolation and culture-expansion methods of mesenchymal stem/progenitor cells from umbilical cord blood and differentation method of umbilical cord blood-derived mesenchymal stem/progenitor cells into
10/25/2006CN1281621C Method of diagnosing and treating heritage spasm paraplegia using NIPAl gene mutation hot point
10/25/2006CN1281191C Mfg. system, its controller, control method and control system
10/24/2006US7127355 Methods for genetic analysis
10/24/2006US7125996 Fluorescent probes for use in protein kinase inhibitor binding assay
10/24/2006US7125981 Ribosomal DNA sequence for detection of activated sludge bacterial strain; biodegradation; bioremediation
10/24/2006US7125980 Diagnostic for organisms key to health of activated sludge wastewater systems
10/24/2006US7125979 Upstream control elements of the proopiomelanocortin gene and their use
10/24/2006US7125975 Derivatized oligonucleotides having improved uptake and other properties
10/24/2006US7125974 Viral sequences
10/24/2006US7125972 Solid support for use in the detect of preferential nucleotide sequences in sample
10/24/2006US7125971 Full-length genomic RNA of papaya leaf-distortion mosaic virus
10/24/2006US7125970 Host cells; drug screening; antigrowth agents
10/24/2006US7125947 Used to form a functionalized coating on substrate; array of nucleic acids may be covalently attached to substrate to make high density arrays to nucleic acids immobilized on substrate which may be used in high volume nucleic acid hybridization
10/24/2006US7125857 A synthetic oligonucleotide comprising a C-5 methylcytosine recognizes and binds an allosteric site on DCTMase and suppressed its catalytic activity; anticarcinogenic and tumor agents; developmental disorders; drug resistance
10/24/2006US7125842 Anti-fungal compounds and methods of use
10/24/2006US7125839 Chimeric molecules that contain at least one pathogen-detection domain and at least one effector domain; use in preventing or treating a pathogen infection in a cell or organism
10/24/2006US7125728 Determination of pregnancy status in cattle and sheep
10/24/2006US7125723 Quantitative analysis of oxidative adjustment of proteins; obtain protein, remove low-molecular weight antioxidant, generate free radical, measure antioxidant activity
10/24/2006US7125717 Metabolically activated recombinant viral vectors and methods for their preparation and use
10/24/2006US7125716 Culturable mitochondrial cells with no nucleus, showing mitochondrial activity
10/24/2006US7125714 Progenitor cell materials and methods
10/24/2006US7125710 Apparatus for measuring the genetic sequence of biopolymers
10/24/2006US7125701 Aggrecanase molecules
10/24/2006US7125700 Cyclic GMP dependent protein kinase as a chemotherapeutic target for antiprotozoal agents
10/24/2006US7125691 Monitoring nucleotide sequences accumulation; obtain sample, dilute, propagate, monitor accumulation of nucleotide sequences
10/24/2006US7125687 Presenilin enhancers assays
10/24/2006US7125685 Stable isotope, site-specific mass tagging for protein identification
10/24/2006US7125684 Treating fertility disorders; maternal-antigen-that-embryos-require (MATER)
10/24/2006US7125683 Preparations for diagnosis extrapancreatic secretory function
10/24/2006US7125682 Methods for measuring protein kinase and phosphatase activity
10/24/2006US7125681 Diagnosing cancer in humans; obtain urine, incubate with antibody, detect complex formation, the presence of complex indicates cancer disorders
10/24/2006US7125679 Methods to screen peptide libraries using minicell display
10/24/2006US7125676 Modified human sodium channel type 1 alpha subunit (SCN1A) nucleic acid that encodes an SCN1A voltage-gated sodium channel polypeptide that regulates Na+ ion membrane permeation; identifying a sodium channel modulator
10/24/2006US7125675 Method for inhibiting tumor invasion or spreading in a subject
10/24/2006US7125674 Microfabricated flowthrough porous apparatus for discrete detection binding reactions
10/24/2006US7125673 Preparing DNA from paraffin-embedded, formalin-fixed tissue samples for promoter methylation analysis by deparaffinizing the samples; boiling them in citrate buffer; and extracting DNA from them; hypermethylation of ATM gene promoter correlates with decreased overall head & neck cancer survival
10/24/2006US7125672 Codon-optimized genes for the production of polyunsaturated fatty acids in oleaginous yeasts
10/24/2006US7125671 Terminal phosphate labeled nucleotide; detection after enzyme activation; quantitative analysis; stabilizer to reduce background interference
10/24/2006US7125670 Comprises activated CD4 T-cells (ACT-4-L) ligand polypeptide for detection of immunomodulators; autoimmune diseases; drug screening; immunosuppressants; viricides
10/24/2006US7125669 Solid-phase immobilization of proteins and peptides
10/24/2006US7125668 Site-selective modification of nucleic acids with electron transfer moieties and electrodes to produce a new class of biomaterials
10/24/2006US7125667 Polymorphic markers of the LSR gene
10/24/2006US7125666 A nucleic acid encodes the polypeptide or fragment has ability to form a triple helix, form higher order collagen fibrils or fibers and provide tensile strenght or flexibility to muscle connective tissue, recognized by R34 antibody
10/24/2006US7125665 Detection of nucleic acid target sequences by electron paramagnetic resonance spectroscopy
10/24/2006US7125664 Detection regulatory genes; obtain nucleotide sequences, deposit on grid, mutate preferential gene sequences, monitor and evaluate gene expression
10/24/2006US7125663 Genes, compositions, kits and methods for identification, assessment, prevention, and therapy of cervical cancer
10/24/2006US7125662 Identifying microorganismal nucleotide sequences associated with antibiotic resistance protein for use as components to improve identification of vector transformed cells
10/24/2006US7125661 Sequences for the detection of Escherichia coli
10/24/2006US7125660 Nucleic acid sensor molecules and methods of using same
10/24/2006US7125659 Method and screening candidate compounds for drug against tumor
10/24/2006US7125658 Small protein that interacts with a ribonucleotide reductase subunit and uses thereof
10/24/2006US7125557 Isolated haemocyanin polypeptide having a specific amino acid sequence recombinantly expressed in a host cell, wherein the glycosylation pattern is different from naturally occurring KLH from Megathura crenulata; may be bonded to a virus, bacteria, DNA, carbohydrate, peptide or glycoprotein
10/24/2006US7125556 Nucleic acid molecule comprising a nucleic acid sequence coding for a haemocyanin
10/24/2006US7125481 Electrochemical-sensor design
10/24/2006CA2273549C Diagnostic agents for pancreatic exocrine function
10/24/2006CA2253041C Chemical indicator for oxidation-type sterilization processes using bleachable dyes
10/24/2006CA2211165C Methods for sensitive detection of reverse transcriptase
10/24/2006CA2104508C Improved method for nucleic acid amplification
10/19/2006WO2006110852A1 System for producing synthetic promoters
10/19/2006WO2006110827A2 Constricting gel assay and therapeutic patch
10/19/2006WO2006110735A2 Genotyping hla loci
10/19/2006WO2006110680A1 Rapid generation of long synthetic centromeric tandem repeats for mammalian artificial chromosome formation
10/19/2006WO2006110601A2 The genetic risk assessment in heart failure: impact of the genetic variation of nos3
10/19/2006WO2006110594A2 Sema4d in cancer diagnosis, detection and treatment
10/19/2006WO2006110593A2 Biological targets for the diagnosis, treatment and prevention of cancer
10/19/2006WO2006110585A2 Cancer-related genes (prlr)
10/19/2006WO2006110581A2 Cancer-related genes
10/19/2006WO2006110504A1 Oxidizable species as an internal reference in control solutions for biosensors
10/19/2006WO2006110466A2 CANCER-RELATED GENES (PTPϵ)
10/19/2006WO2006110457A1 Layered support sheet for high-yield spot cutting from gels or membranes
10/19/2006WO2006110449A2 Agglomeration protein cascades, compositions and methods regarding the same
10/19/2006WO2006110358A2 Methods and compositions for introducing biopolymers into cells
10/19/2006WO2006110264A2 Methods and compositions for predicting death from cancer and prostate cancer survival using gene expression signatures
10/19/2006WO2006110214A2 Antibodies against mammalian metapneumovirus
10/19/2006WO2006110212A2 Dynamically expressed genes with reduced redundancy
10/19/2006WO2006110182A2 Orthogonal translation components for the in vivo incorporation of unnatural amino acids
10/19/2006WO2006110166A2 Functionalized nanostructures with liquid-like behavior
10/19/2006WO2006110161A2 Method for identification and quantification of short or small rna molecules
10/19/2006WO2006110152A2 Lined multi-well plates
10/19/2006WO2006109858A1 Method for cleavage of sugar chain from glycoprotein, mass spectrometry for sugar chain, and mass spectrometry for glycoprotein
10/19/2006WO2006109855A1 Peptide having food intake stimulating effect and method for screening for the peptide
10/19/2006WO2006109693A1 Sampling device for viscous sample, method of homogenizing sputum and method of detecting microorganism
10/19/2006WO2006109578A1 Altered pyrroloquinoline-quinone-dependent glucose dehydrogenase and method of improving substrate specificity of pyrroloquinoline-quinone-dependent glucose dehydrogenase
10/19/2006WO2006109424A1 Dnas encoding protein having function of forming and regulating cellulosic fiber cell wall in tree trunk and promoter dnas of the same
10/19/2006WO2006109420A1 Method of examining plant qualities and species
10/19/2006WO2006109283A1 A method for detecting c. albicans
10/19/2006WO2006109280A2 Method and apparatus for detection of abnormal traces during electrochemical analyte detection
10/19/2006WO2006109279A2 Analyte determination method and analyte meter
10/19/2006WO2006109278A2 Method for determination of analyte concentrations and related apparatus
10/19/2006WO2006109193A2 Selection of highly efficient antigen presenting cells for regulating immunity and uses thereof
10/19/2006WO2006109086A2 Method to predict the sensitivity of tumors to eg5 inhibitors
10/19/2006WO2006108905A1 In vitro cancer therapy compound identification method
10/19/2006WO2006108811A1 Analysis device with replaceable test field support
10/19/2006WO2006108675A2 Elite event a5547-127 and methods and kits for identifying such event in biological samples
10/19/2006WO2006108674A2 Elite event a2704-12 and methods and kits for identifying such event in biological samples
10/19/2006WO2006108659A2 Gene expression profiles being predictive for the response of tumors to pharmaceutically effective compounds
10/19/2006WO2006108627A1 Anti-egfr antibody therapy based on an increased copy number of the egfr gene in tumor tissues